Post Partum Hemorrhage Clinical Trial
Official title:
Is Early Intervention Using Mansoura-VV Uterine Compression Sutures an Effective Procedure in the Management of Primary Atonic Postpartum Hemorrhage? : A Prospective Study
Postpartum hemorrhage is the leading cause of maternal, uterine atony accounts for 75-90% of primary postpartum hemorrhage. The efficacy of the Uterine compression suture in the treatment of atonic postpartum hemorrhage is time-tested and can be said to be almost established .The aim of this study was to assess the role of the Mansoura-VV uterine compression suture as an early intervention in the management of primary atonic postpartum hemorrhage.
This prospective observational study was carried out at the Obstetrics and Gynecology
Department Mansoura University Hospital, and private settings in Mansoura, Egypt, during the
period from May 2013 to December 2016. Inclusion criteria included women diagnosed with
primary atonic PPH, during cesarean section when the uterus failed to contract after the
routine doses of uterotonics. Women and their partners were counseled and signed a consent
regarding the technique as an alternative to devascularization or hysterectomy. Exclusion
criteria included patients with placenta previa complete or incomplete centrails, and/or
placenta accreta. Also one case of atonic PPH, when the uterus was incompressible and failed
to contract on bimanual compression was excluded from the study, as in our experience these
cases failed to respond to any type of UCS.
In this series, immediately after anesthesia, all women received misoprostol 400 mcg (two
tablets of MisotacR, Adwia Co, 6th October city, Egypt) sublingual, as well as 20 IU of
oxytocin (Syntocinon, Sanofi Aventais, Egypt) in 50 0-mL lactated Ringer's solution as an
intravenous infusion, after delivery of the baby and clamping of the umbilical cord. This is
routine practice for all women undergoing CS in our department.
After closure of the uterine incision, uterine atony was diagnosed in 108 women when the
uterus felt soft and flappy, and failed to respond to intermittent fundal massage, the
second dose of the previously mentioned ecbolics was given. Then, bimanual compression of
the uterus was attempted for 10 to 15 minutes until the tone of the uterus is regained as
well as to assess the potential chances of success of the Mansoura-VV uterine compression
suture.
Within 15 minutes of the diagnosis, the uterus was rechecked to identify any bleeding
points. the investigators performed Mansoura-VV uterine compression suture. The right V was
performed as follow: (i) 100-cm Vicryl no. 1 was thrown to form two nearly equal parts (each
50 cm) on a blunt semicircular 70-mm needle, the curve of the needle was straightened. (ii)
The needle transfixed the right uterine wall from anterior to posterior, about 2 cm below
the hysterotomy incision and 3 cm from the (this represents the apex of the V suture). (iii)
after transfixation, the Vicryl was divided thus two threads from one transfixation each
50-cm threads penetrated the lower uterine segment; medial (M) and lateral (L) threads, each
has anterior (aL and aM) and posterior (pL and pM) ends in relation to the uterus (iv) The
free anterior and posterior ends of the lateral thread (aL and pL) were tied above the
fundus with three double - throw knots about 3 cm from the right cornual border of the
uterus forming the lateral limb of the V suture. (v) The free anterior and posterior ends of
the medial threads (aM and pM) were tied above the fundus 2-3 cm medial to the lateral limb
completing the V suture . The lead surgeon pulled the suture to provide moderate tension,
while the assistant surgeon lift the uterus upward while perform a bimanual uterine
compression to minimize trauma and to achieve or aid compression during the ligation of each
vertical limb. (vi) using a similar technique, the left V suture was laid on the left side,
and then the VV suture is completed.
The vagina was inspected to check for control of bleeding with Mansoura-VV sutures, the
uterus cannot be stretched. Only one case (1/108) required additional bilateral uterine
vessels ligation for control of bleeding, the abdomen was closed routinely. Antibiotics were
given and continued postoperatively for 5 days.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03680339 -
The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS
|
Phase 4 | |
Completed |
NCT03693599 -
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
|
Phase 4 | |
Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
Recruiting |
NCT02306733 -
Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
|
Phase 3 | |
Completed |
NCT01866241 -
Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
|
Phase 3 | |
Not yet recruiting |
NCT01236482 -
Oxytocin in Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03784794 -
Patient Blood Management for Massive Obstetric Hemorrhage
|
N/A | |
Enrolling by invitation |
NCT06255496 -
QStat Cartridge in Obstetric Patients
|
||
Recruiting |
NCT04401839 -
Amr Maneuver for Prevention of Postpartum Hemorrhage
|
N/A | |
Recruiting |
NCT06219538 -
DAISY Uterine Drain Device Evaluation
|
N/A | |
Not yet recruiting |
NCT06333340 -
Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery
|
N/A | |
Completed |
NCT01863706 -
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
|
Phase 1 | |
Completed |
NCT04723979 -
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
|
||
Terminated |
NCT04277962 -
Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial
|
N/A | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Active, not recruiting |
NCT03069859 -
Use of TXA to Prevent Postpartum Hemorrhage
|
Phase 2 | |
Not yet recruiting |
NCT03891082 -
A Comparative Study Between Bakri Balloon and B Lynch Suture Used to Control Primary Postpartum Hemorrhage After Cesarean Section
|
N/A | |
Not yet recruiting |
NCT03463070 -
Misoprostol Before and After Cesarean Section
|
Phase 3 | |
Recruiting |
NCT05532215 -
Sublingual Misoprostol in Reduction of Caesarean Blood Loss
|
N/A | |
Completed |
NCT03907605 -
Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)
|